BCL2 and acute lymphoblastic leukemia: It has also been recently reported that BEZ235 synergizes with the Bcl-2 inhibitor, GX15-070 (Obatoclax), in Ph+ and Ph− primary B-ALL cells [181], representing a potent approach to counteract growth and survival of ALL cells.